143 related articles for article (PubMed ID: 2157655)
1. Beta-endorphin, insulin, ACTH and cortisol plasma levels during oral glucose tolerance test in obesity after weight loss.
Giovannini C; Ciucci E; Clementi R; Cugini P; Facchinetti F; Negri M
Horm Metab Res; 1990 Feb; 22(2):96-100. PubMed ID: 2157655
[TBL] [Abstract][Full Text] [Related]
2. Plasma beta-endorphin in response to oral glucose tolerance test in obese patients.
Scavo D; Facchinetti F; Barletta C; Petraglia F; Buzzetti R; Monaco M; Giovannini C; Genazzani R
Horm Metab Res; 1987 May; 19(5):204-7. PubMed ID: 3034755
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation of leptin levels in plasma and their reliance on other hormonal factors affecting tissue fat levels in people with various levels of endogenous cotisol].
Robaczyk MG
Ann Acad Med Stetin; 2002; 48():283-300. PubMed ID: 14601484
[TBL] [Abstract][Full Text] [Related]
4. [Plasma levels of beta-endorphin , ACTH and cortisol in obese patients subjected to several weight-loss treatments].
Giovannini C; Ciucci E; Facchinetti F
Recenti Prog Med; 1990 May; 81(5):301-5. PubMed ID: 2165628
[TBL] [Abstract][Full Text] [Related]
5. The effect of vertical banded gastroplasty on glucose-induced beta-endorphin response.
Karayiannakis AJ; Syrigos KN; Zbar A; Makri GG; Athanasiadis L; Alexiou D; Bastounis EA
J Surg Res; 1998 Dec; 80(2):123-8. PubMed ID: 9878302
[TBL] [Abstract][Full Text] [Related]
6. [Effect of naloxone on beta-endorphin and insulin concentrations during glucose tolerance testing in patients with simple obesity].
Krzyzanowska-Swiniarska B; Gruszczyńska M; Pilarska K; Widecka K; Czekalski S
Endokrynol Pol; 1993; 44(4):517-29. PubMed ID: 8055820
[TBL] [Abstract][Full Text] [Related]
7. [Plasma levels of beta-endorphin in obese subjects with normal glucose tolerance test and in diabetics].
Donatelli M; Terrizzi C; Russo V; Bucalo ML; Scarpinato A; Verga S; Puglisi S; Miceli G; Iraci T; Bompiani GD
Recenti Prog Med; 1991 Jan; 82(1):1-3. PubMed ID: 2028070
[TBL] [Abstract][Full Text] [Related]
8. Plasma beta-endorphin levels and glucose tolerance in patients with chronic renal failure.
Barreca T; Robaudo C; Cataldi A; Garibaldi A; Cianciosi P; Russo R; Rolandi E; Franceschini R
Biomed Pharmacother; 1995; 49(6):283-7. PubMed ID: 7579009
[TBL] [Abstract][Full Text] [Related]
9. Beta-endorphin plasma levels and their dependence on gender during an enteral glucose load in lean subjects as well as in obese patients before and after weight reduction.
Ritter MM; Sönnichsen AC; Möhrle W; Richter WO; Schwandt P
Int J Obes; 1991 Jun; 15(6):421-7. PubMed ID: 1885266
[TBL] [Abstract][Full Text] [Related]
10. Secretion of major adrenal androgens following ACTH administration in obese women with different body fat distribution.
Vicennati V; Calzoni F; Gambineri A; Gagliardi L; Morselli Labate AM; Casimirri F; Pasquali R
Horm Metab Res; 1998 Mar; 30(3):133-6. PubMed ID: 9566854
[TBL] [Abstract][Full Text] [Related]
11. [Plasma levels of beta-endorphin and ACTH and serum levels of cortisol in different stages of arterial hypertension before and after clonidine therapy].
Barletta C; Scavo D
Minerva Med; 1990 May; 81(5):363-70. PubMed ID: 2165579
[TBL] [Abstract][Full Text] [Related]
12. Absent B-endorphin response to clonidine in obese children.
Facchinetti F; Bernasconi S; Petraglia F; Marcellini C; Iughetti L; Genazzani AR
Horm Metab Res; 1988 Jun; 20(6):348-51. PubMed ID: 2971010
[TBL] [Abstract][Full Text] [Related]
13. Effects of caloric restriction and exercise on B-endorphin, ACTH and cortisol circulating levels in obesity.
Scavo D; Barletta C; Buzzetti R; Vagiri D
Physiol Behav; 1988; 42(1):65-8. PubMed ID: 2838854
[TBL] [Abstract][Full Text] [Related]
14. Predicting cardiovascular risk factors from plasma cortisol measured during oral glucose tolerance tests.
Reynolds RM; Syddall HE; Walker BR; Wood PJ; Phillips DI
Metabolism; 2003 May; 52(5):524-7. PubMed ID: 12759878
[TBL] [Abstract][Full Text] [Related]
15. Massive weight loss decreases corticosteroid-binding globulin levels and increases free cortisol in healthy obese patients: an adaptive phenomenon?
Manco M; Fernández-Real JM; Valera-Mora ME; Déchaud H; Nanni G; Tondolo V; Calvani M; Castagneto M; Pugeat M; Mingrone G
Diabetes Care; 2007 Jun; 30(6):1494-500. PubMed ID: 17526821
[TBL] [Abstract][Full Text] [Related]
16. Obesity is associated with increased post-prandial GIP levels which are not reduced by dietary restriction and weight loss.
Jones IR; Owens DR; Luzio SD; Hayes TM
Diabete Metab; 1989; 15(1):11-22. PubMed ID: 2721810
[TBL] [Abstract][Full Text] [Related]
17. Plasma B-endorphin resistance to dexamethasone suppression in obese patients.
Facchinetti F; Giovannini C; Petraglia F; Barletta C; Comitini G; Genazzani AR
J Endocrinol Invest; 1988 Feb; 11(2):119-23. PubMed ID: 2834430
[TBL] [Abstract][Full Text] [Related]
18. Influence of insulin on beta-endorphin plasma levels in obese and normal weight subjects.
Brunani A; Pincelli AI; Pasqualinotto L; Tibaldi A; Baldi G; Scacchi M; Fatti LM; Cavagnini F
Int J Obes Relat Metab Disord; 1996 Aug; 20(8):710-4. PubMed ID: 8856392
[TBL] [Abstract][Full Text] [Related]
19. Decreased basal levels of glucagon-like peptide-1 after weight loss in obese subjects.
de Luis DA; Gonzalez Sagrado M; Conde R; Aller R; Izaola O
Ann Nutr Metab; 2007; 51(2):134-8. PubMed ID: 17536190
[TBL] [Abstract][Full Text] [Related]
20. Training responses of plasma beta-endorphin, adrenocorticotropin, and cortisol.
Kraemer WJ; Fleck SJ; Callister R; Shealy M; Dudley GA; Maresh CM; Marchitelli L; Cruthirds C; Murray T; Falkel JE
Med Sci Sports Exerc; 1989 Apr; 21(2):146-53. PubMed ID: 2540392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
